menu search

NBSE / NeuBase (NBSE) Surges 107% on New Shareholder Acquiring Stake

NeuBase (NBSE) Surges 107% on New Shareholder Acquiring Stake
With NeuBase (NBSE) exploring strategic alternatives to the company, Symetryx joins the company's shareholder base and urges the board to issue a unique $1 per share dividend. Read More
Posted: Sep 7 2023, 12:47
Author Name: Zacks Investment Research
Views: 042197

NBSE News  

NeuBase (NBSE) Surges 107% on New Shareholder Acquiring Stake

By Zacks Investment Research
September 7, 2023

NeuBase (NBSE) Surges 107% on New Shareholder Acquiring Stake

With NeuBase (NBSE) exploring strategic alternatives to the company, Symetryx joins the company's shareholder base and urges the board to issue a uniq more_horizontal

Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?

By InvestorPlace
September 6, 2023

Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?

NeuBase Therapeutics (NASDAQ: NBSE ) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company. There ar more_horizontal

What Makes NeuBase (NBSE) a New Strong Buy Stock

By Zacks Investment Research
January 20, 2023

What Makes NeuBase (NBSE) a New Strong Buy Stock

NeuBase (NBSE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). more_horizontal

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

By GlobeNewsWire
March 7, 2022

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech more_horizontal

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

By GlobeNewsWire
March 7, 2022

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech more_horizontal

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

By GlobeNewsWire
March 7, 2022

NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference

PITTSBURGH and CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotech more_horizontal


Search within

Pages Search Results: